Clinical Trial

Pragmatic Trial of Obsessive-compulsive Disorder

Study acronym: Proceed
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study includes a sequenced clinical trial in order to assess the efficacy of several switching or augment strategies when initial treatment is ineffective，and to provide strong evidence for clinical practice and international guidelines for Obsessive-Compulsive Disorder treatments.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-09-01; most recent amendment 2025-05-12.
Status change: Not Yet Recruiting → Recruiting 2020-10-19
Trial Details
NCT Number NCT04539951
Lead Sponsor Shanghai Mental Health Center
Collaborators: The first specialized hospital of harbin, Guizhou Provincial People's Hospital, First Affiliated Hospital of Jinan University, West China Hospital, Suzhou Psychiatric Hospital, Nanjing Medical University, Wuhan Mental Health Centre, Seventh People's Hospital of Hangzhou, First Affiliated Hospital of Kunming Medical University, General Hospital of Ningxia Medical University, The First Affiliated Hospital of Nanchang University, The Second Affiliated Hospital of Xinxiang Medical University
Conditions Obsessive-Compulsive Disorder
Enrollment 1,600 participants
Start Date 2020-09-22
Primary Completion 2027-06-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-15